CAS RN: 2070015-22-2

ILK-IN-2

Product Availability

Choose a grade to view its available package options.

8 package records4 with current stock1 grade group
Batch No.PackageAvailabilityWarehouseInquiry
Batchno.20250927 100mg Out of stock Inquiry
Batchno.20260525 10mg In stock Shanghai, Wuhan Inquiry
Batchno.20250308 1mg In stock Shanghai, Wuhan Inquiry
Batchno.20250708 250mg Out of stock Inquiry
Batchno.20251215 25mg Out of stock Inquiry
Batchno.20260426 50mg Out of stock Inquiry
Batchno.20250304 5mg In stock Shanghai, Wuhan Inquiry
Batchno.20250805 5mg / 10mg / 50mg Confirm by inquiry Shanghai Inquiry
  • Product code: starshine_CAS2070015-22-2
  • Purity/Analytical Methods: >99.0%
GET A QUOTE

2070015-22-2 / N-methyl-3-[1-(4-piperazin-1-ylphenyl)-3-[4-[4-(trifluoromethyl)phenyl]phenyl]pyrazol-5-yl]propanamide

Standard CAS: 2070015-22-2 Multi CAS: No

Basic Information

CAS
2070015-22-2
Multi CAS
No
Molecular Formula
C30H30F3N5O
Molecular Weight
533.600000
Exact Mass
533.240245
SMILES
CNC(=O)CCC1=CC(=NN1C2=CC=C(C=C2)N3CCNCC3)C4=CC=C(C=C4)C5=CC=C(C=C5)C(F)(F)F
InChI
InChI=1S/C30H30F3N5O/c1-34-29(39)15-14-27-20-28(36-38(27)26-12-10-25(11-13-26)37-18-16-35-17-19-37)23-4-2-21(3-5-23)22-6-8-24(9-7-22)30(31,32)33/h2-13,20,35H,14-19H2,1H3,(H,34,39)
InChIKey
AJLOJUFSIDSBNN-UHFFFAOYSA-N

Computed Properties

Structural Parameters

Heavy atom count
39
Aromatic heavy atom count
23
Fraction Csp3
0.27
Rotatable bonds
7
H-bond acceptors
5
H-bond donors
2
Molar refractivity
146.91
TPSA
62.19

LogP / Solubility

WLOGP
5.31
MLOGP
4.72
XLogP3
5.1
Consensus LogP
5.04
Log S (ESOL)
-6.47
Class (ESOL)
Insoluble
Log S (Ali)
-7.77
Class (Ali)
Insoluble
Log S (SILICOS-IT)
-8.38
Class (SILICOS-IT)
Insoluble

ADME

GI absorption
High
BBB permeant
No
P-gp substrate
No
CYP1A2 inhibitor
No
CYP2C19 inhibitor
Yes
CYP2C9 inhibitor
Yes
CYP2D6 inhibitor
Yes
CYP3A4 inhibitor
Yes
Log Kp (skin permeation)
-2.2

Drug-likeness / Medicinal Chemistry

Lipinski
No
Ghose
No
Veber
Yes
Egan
Yes
Muegge
No
Bioavailability score
0.56
PAINS alerts
1
Leadlikeness
No
Synthetic Accessibility
5

Get In Touch

Contact Us